Eric Hink, MD
Ophthalmology
Locations
Practice Locations
UCHealth Sue Anschutz-Rodgers Eye Center
720-848-2020
UCHealth Eye Center - Boulder
303-545-2020
UCHealth Ambulatory Surgery Center - Cherry Creek Medical Center
720-516-9373
Children's Hospital Colorado Anschutz Medical Campus
Aurora
720-777-1234
CU Medicine Ophthalmology - Oculoplastic Surgery
UCHealth Cherry Creek Medical Center
720-848-2020
UCHealth Eye Center - Cherry Creek
720-553-2020
Provider Expertise
Clinical Interest for Patients
My interests include eyelid cancer and reconstruction, orbital trauma and reconstruction, thyroid eye disease, lacrimal surgery, and aesthetic facial surgery.
Specialties
- Ophthalmology ( 2010 )
Conditions & Treatments
-
Injuries and Wounds
-
Skin, Hair and Nails
Biopsies and Excisions
-
Cancers
Cancer Surgery, Eye, Head and Neck Cancer, Melanoma, Pediatric Cancer, Skin Cancer
-
Eyes and Vision
Eye Disease, Oculofacial Plastic and Orbital Surgery, Ophthalmic Oncology, Pediatric Ophthalmology and Adult Strabismus
-
Bones, Joints and Muscles
Facial Fractures
-
Ear, Nose, and Throat (ENT)
Facial Paralysis, Facial Plastics and Cosmetics, Head and Neck Tumors
-
Surgery
Eye and/or Orbital, Plastic, Reconstructive and Aesthetic, Trauma and Acute Care
-
Endocrine System (Hormones)
Thyroid Disease
Education & Training
Medical Schools
MD, University of Colorado Denver School of Medicine (2004)
Undergraduate Schools
BS, University of Washington (WA) (1995)
Internships
Presbyterian-St Luke's Medical Center Program (2005)
Residency Program
University of Colorado (2008)
Fellowships
University of Colorado (2010)
Professional Memberships
Alpha Omega Alpha Honor Society (AOA), Member
American Academy of Ophthalmology (AAO), Member
American Board of Ophthalmology (ABO), Diplomate
American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS), Fellow
Research & Grants
Grants
A multicenter, double-masked, placebo-controlled, efficacy and safety study of RV 001, an insulin-like growth factor-1 receptor (IGF-1R) antagonist antibody (fully human), administered every 3 weeks (q3W) by intravenous (iv) infusion in patients suff (2013)
The Sinopsys Lacrimal Stent for Lacrimal System Repair in Epiphora (2014)
information for referring providers
Referral Contact Phone
(720) 848-2020
Referral Contact Fax
720-848-5079
Clinical Interests for Referring Providers
My interests include eyelid cancer and reconstruction, orbital trauma and reconstruction, thyroid eye disease, lacrimal surgery, and aesthetic facial surgery.
Research Interest for Referring Providers
My interests include eyelid cancer and reconstruction, orbital trauma and reconstruction, thyroid eye disease, lacrimal surgery, and aesthetic facial surgery.
